期刊文献+

阿托伐他汀治疗老年性心肌梗死患者的疗效及对血脂水平的影响 被引量:2

Effect of atorvastatin on elderly patients with myocardial infarction and its effect on blood lipid level
下载PDF
导出
摘要 目的:探讨阿托伐他汀治疗老年性心肌梗死的疗效及对血脂的影响。方法:收治老年性心肌梗死患者90例,随机分为试验组与对照组各45例。在综合治疗的基础上,试验组给予阿托伐他汀治疗;对照组给予辛伐他汀治疗。结果:试验组治疗后的hs-cTnI、CK-MB、TC、TG均优于对照组(P<0.05);试验组恶性心律失常率低于对照组(P<0.05)。结论:阿托伐他汀治疗老年性心肌梗死患者的疗效较好,能够显著改善血脂水平,且无明显不良反应发生。 Objective:To investigate the effect of atorvastatin on elderly patients with myocardial infarction and its effect on blood lipid level.Methods:90 elderly patients with myocardial infarction were selected.They were randomly divided into the experimental group and the control group with 45 cases in each group.On the basis of comprehensive treatment,the experimental group were given atorvastatin,while the control group was treated with simvastatin.Results:The hs-cTnI,CK-MB,TC and TG in the experimental group were better than those in the control group(P<0.05);the arrhythmia rate of the experimental group was lower than that of the control group(P<0.05).Conclusion:The curative effect of atorvastatin in the treatment of elderly patients with myocardial infarction is good.It can improve the level of blood lipids significantly,with no significant adverse reactions.
作者 尹萍 孔丽凤 李敏 Yin Ping;Kong Lifeng;Li Min(Department of the Second Internal,China Petroleum Urumqi Petrochemical Co Staff Hospital 830019;Department of Endocrine,Sixth Affiliated Hospital of Xinjiang Medical University 830002)
出处 《中国社区医师》 2017年第7期24-24,26,共2页 Chinese Community Doctors
关键词 阿托伐他汀 老年性心肌梗死 血脂水平 Atorvastatin atorvastatin Senile myocardial infarction Blood lipid level
  • 相关文献

参考文献5

二级参考文献52

  • 1张捷,贾珂珂,胡晓舟,崔丽艳.血清NT-proBNP和CRP水平对AMI后左室重构的预测价值[J].临床检验杂志,2006,24(2):91-93. 被引量:17
  • 2KIERNAN T J, RUGGIERO N J, BERNAL J M, et al. The no-reflow phenomenon in the coronary cireulation[J]. Cardiovasc Hematol Agents Med Chem,2009,7:181 -192.
  • 3BROSH D, ASSALI A R, MAGER A, et al. Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six- month mortality[J]. Am J Cardiol, 2007,99:442 - 445.
  • 4VRINTS C J. Pathophysiology of the no-reflow phenomenon[J]. Acute Card Care, 2009,11 : 69- 76.
  • 5PASCERI V, PATTI G, NUSCA A, et al. Randomized trial:of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioptasty) study[J]. Circulation,2004,110:674-678.
  • 6PATTI G, PASCERI V, COLONNA G, et al. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early per- cutaneous coronary intervention: results of the ARMYDA-ACS randomized trial[J]. J Am Coll Cardiol, 2007,49 : 1272- 1278.
  • 7GIBSON C M, CANNON C P, DALEY W L, et al. TIMI frame count: a quantitative method of assessing coronary artery flow[J]. Circulation, 1996,93 : 879 - 888.
  • 8IWAKURA K, ITO H, KAWANO S, et al. Chronic pretreatment of statins is associated with the reduction of the no-reflow phenomenon in the patients with reperfused acute myocardial infarction[J]. Eur Heart J, 2006,27 : 534- 539.
  • 9SEJERSTEN M, VALEUR N, GRANDE P, et al. Long term prognostic value of ST-segment resolution in patients treated with fibrinolysis or primary percutaneous coronary intervention results from the DANAMI-2 (DANish trial in acute myocardial infarction- 2)[J]. J Am Coll Cardiol,2009,54:1763-1769.
  • 10BASSUK S S, RIFAI N, RIDKER P M. High-sensitivity C-reactive protein: clinical importance[J]. Curr Probl Cardiol, 2004,29: 439-493.

共引文献157

同被引文献12

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部